Unique genomic features in adolescent and young adult, as compared to older adult, non-Hodgkin lymphoma and potential therapeutic targets.
Foundation Medicine, Inc., Cambridge, MA, USA.
Adrienne
A
Johnson
Foundation Medicine, Inc., Cambridge, MA, USA.
Deborah
D
Morosini
Foundation Medicine, Inc., Cambridge, MA, USA.
Jo-Anne
JA
Vergilio
Foundation Medicine, Inc., Cambridge, MA, USA.
Roman
R
Yelensky
Foundation Medicine, Inc., Cambridge, MA, USA.
Mark
M
Rosenzweig
Foundation Medicine, Inc., Cambridge, MA, USA.
Depinder
D
Khaira
Foundation Medicine, Inc., Cambridge, MA, USA.
Siraj M
SM
Ali
Foundation Medicine, Inc., Cambridge, MA, USA.
Norma
N
Palma
Foundation Medicine, Inc., Cambridge, MA, USA.
Doron
D
Lipson
Foundation Medicine, Inc., Cambridge, MA, USA.
Frank
F
Juhn
Foundation Medicine, Inc., Cambridge, MA, USA.
Rachel
R
Erlich
Foundation Medicine, Inc., Cambridge, MA, USA.
Philip J
PJ
Stephens
Foundation Medicine, Inc., Cambridge, MA, USA.|Albany Medical College, Albany, NY, USA.
Jeffrey S
JS
Ross
Foundation Medicine, Inc., Cambridge, MA, USA.
Vincent A
VA
Miller
Foundation Medicine, Inc., Cambridge, MA, USA.|Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China.
Kai
K
Wang
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor; D056726:Genetic Association Studies; D020022:Genetic Predisposition to Disease; D014644:Genetic Variation; D023281:Genomics / Q000379:methods; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy / Q000235:genetics* / Q000378:metabolism; D008875:Middle Aged; D058990:Molecular Targeted Therapy; D055815:Young Adult
D014408:Biomarkers, Tumor
adolescents and young adults; comprehensive genomic profiling; next-generation sequencing; non-Hodgkin lymphoma; targeted therapy